Pomaglumetad methionil (INN, USAN; developmental code names LY-2140023 and LY-2812223) is a metabotropic glutamate mGlu2 and mGlu3 receptor agonist which is or was under development for the treatment of schizophrenia, substance-related disorders, and post-traumatic stress disorder (PTSD).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.